Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.51M Buy
+325,400
New +$1.91M 0.01% 1607
2017
Q3
Sell
-97,200
Closed -$534K 4308
2017
Q2
$534K Buy
97,200
+88,800
+1,057% +$506K ﹤0.01% 2472
2017
Q1
$48K Buy
+8,400
New +$46.1K ﹤0.01% 3848
2015
Q4
Sell
-3,100
Closed -$15K 4652
2015
Q3
$15K Sell
3,100
-26,600
-90% -$144K ﹤0.01% 4919
2015
Q2
$181K Sell
29,700
-12,600
-30% -$77.9K ﹤0.01% 3814
2015
Q1
$244K Buy
42,300
+5,800
+16% +$36K ﹤0.01% 3260
2014
Q4
$227K Sell
36,500
-293,900
-89% -$1.86M ﹤0.01% 3271
2014
Q3
$2.16M Sell
330,400
-103,900
-24% -$732K 0.02% 1174
2014
Q2
$3.06M Buy
434,300
+309,100
+247% +$2.27M 0.03% 804
2014
Q1
$928K Buy
125,200
+119,200
+1,987% +$834K 0.01% 1939
2013
Q4
$44K Buy
+6,000
New +$43.9K ﹤0.01% 4385

Other funds holding ABEV

PEAK6 Group's ABEV Position: Q2 2018 in Review

PEAK6 Group increased its Ambev (ABEV) stake by 1,234% in Q2 2018, buying an estimated $1.13M and bringing the position to 208,622 shares worth $966K. The position accounts for ﹤0.01% of the portfolio, ranked #1987.

PEAK6 Group first reported a position in ABEV in Q4 2013 and has held it in 11 quarters since. The position peaked at $2.44M in Q2 2014. 337 funds tracked by Wall St. Rank hold ABEV as of Q2 2018.

  • PEAK6 Group held 208,622 shares of Ambev worth $966K as of Q2 2018.
  • PEAK6 Group bought 192,983 Ambev shares in Q2 2018, an estimated $1.13M.
  • Ambev made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #1987 holding.
  • PEAK6 Group first reported a position in Ambev in Q4 2013 and has held it in 11 quarters since.
  • PEAK6 Group's Ambev position peaked at $2.44M in Q2 2014.
  • 337 funds tracked by Wall St. Rank held Ambev as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.